Episode 68
Biotech Hangout
00:00
Zoranalone in Major Depressive Disorder and Postpartum Depression
Biogen and Sage are expecting to hear from the FDA on their NDA for Zoranalone in major depressive disorder and postpartum depression. The data's come at the end of the year, early 24. We're optimistic, but if any of you have experienced developing pain drugs, always tricky,. particularly if you're just running one Phase 2 chronic neuropathic pain study.
Transcript
Play full episode
